Showing results (1-10 of 199) with videos related to
Sort By:
Pageof 20
Continuum (Minneapolis, Minn.)|August 1, 2024
Autoimmune Neuromuscular Disorders Associated With Neural AntibodiesDivyanshu DubeyPatient Preference and Adherence|October 22, 2019
Clinical evaluation of dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis: efficacy, safety, patient experience and adherenceBhavya Narapureddy, Divyanshu DubeyNeurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 27, 2019
Autoimmune EpilepsyKhalil S Husari, Divyanshu DubeyNeurology|July 13, 2026
Association of Plasma Neurofilament Light Chain With Diagnostic Classification in a Neuromuscular Referral Cohort: A Cross-Sectional StudyElke S Schipani, Felipe J S Jones, Nathan P Staff, et al.Current Opinion in Critical Care|February 6, 2018
Clinical presentation of autoimmune and viral encephalitidesDivyanshu Dubey, Michel Toledano, Andrew McKeonCurrent Treatment Options in Neurology|April 20, 2016
Managing Disability in Progressive Multiple SclerosisDivyanshu Dubey, Peter Sguigna, Olaf StüveCurrent Opinion in Neurology|March 31, 2016
Update on monitoring and adverse effects of approved second-generation disease-modifying therapies in relapsing forms of multiple sclerosisDivyanshu Dubey, Christopher A Cano, Olaf StüveNeuropsychiatric Disease and Treatment|October 2, 2015
Intractable and highly active relapsing multiple sclerosis - role of alemtuzumabDivyanshu Dubey, Christopher A Cano, Olaf StuveHandbook of Clinical Neurology|March 17, 2024
Paraneoplastic neurologic syndrome and autoantibody accompaniments of germ cell tumorsM Bakri Hammami, Mohamed Rezk, Divyanshu DubeyCurrent Opinion in Neurology|April 2, 2016
Update on monitoring and adverse effects of first generation disease modifying therapies and their recently approved versions in relapsing forms of multiple sclerosisDivyanshu Dubey, Christopher A Cano, Olaf StüvePageof 20